Medicines360 Acquires Global Licensing Rights to Innovative Maternal Health Technologies for Risk Identification and Management Throughout PregnancyLicensing of scientific discoveries from University of Cambridge and University of Edinburgh is aimed to speed translation and access to life-saving diagnostics for women worldwide.
Medicines360 acquires global rights to PeriPeach™, advancing new maternal health technology through the 360 Innovation Hub™SAN FRANCISCO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Medicines360, a women’s health innovation organization with a mission to be a catalyst for change, today announced that it has acquired global licensing rights to PeriPeach, an investigational medical device designed to prevent severe perineal tears during birth, from Fruits of Labor, Inc. PeriPeach will now advance through the 360 Innovation Hub, Medicines360’s platform for accelerating transformative women’s health solutions.
Medicines360 Appoints Erica Rogers to Board of DirectorsRogers brings over 30 years of experience in the medical technology and healthcare sectors to Medicines360
Medicines360 and DKT WomanCare Announce Strategic Partnership to Expand Access to the Hormonal IUD Avibela™Medicines360 and DKT WomanCare are joining forces to increase availability and use of AVIBELA, an affordable, effective, long-acting hormonal IUD developed by Medicines360, across Africa, South and Southeast Asia, Central America, and the Caribbean.
